カテゴリ： Grand View Research, 世界, 医療/バイオ

バイオマーカーの世界市場：種類別（安全性、有効性、検証）、用途別（診断、医薬品開発、個別化医療）、疾患別

◆英語タイトル：Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy, Validation), By Application (Diagnostic, Drug Development, Personalized Medicine), By Disease, And Segment Forecasts, 2020 - 2027
◆商品コード：GV20MY034
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2020年3月5日
◆ページ数：200
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥966,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、バイオマーカーの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、競争分析、種類別（安全性、有効性、検証）分析、用途別（診断、医薬品開発、個別化医療）分析、疾患別（がん、循環器疾患、神経疾患免疫疾患、その他）分析、地域別分析、競争状況などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・競争分析
・バイオマーカーの世界市場：種類別（安全性、有効性、検証）
・バイオマーカーの世界市場：用途別（診断、医薬品開発、個別化医療）
・バイオマーカーの世界市場：疾患別（がん、循環器疾患、神経疾患免疫疾患、その他）
・バイオマーカーの世界市場：地域別
・競争状況
【レポートの概要】

The global biomarkers market size is expected to reach over USD 129.4 billion by 2027, according to a new study conducted by Grand View Research Inc. It is anticipated to exhibiting a CAGR of 13.7%, during the forecast period. Factors, such as increasing collaborations and funds for R&D activities, rising consumer awareness, a widening patient base, and technological advancements collectively augmenting market growth.

The drug discovery segment contributed the highest revenue in 2019. Pharmaceutical companies focus on extensive R&D initiatives for the development of targeted therapeutics. Coordinated strategic efforts on biomarker development remain a searing trend among drug manufacturers, academic research institutions, commercial R&D organizations, nonprofitable health foundations, and federal government biomedical regulatory and research agencies.

North America continued to lead the biomarkers market in 2019, driven by an amplifying demand for personalized medicines, high disease prevalence, and proactive government initiatives. It is expected to maintain its lead over the forecast period. Asia Pacific is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.

Some key market players include Abbott; F. Hoffmann-La Roche Ltd.; Qiagen; Siemens Healthcare Private Limited; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Johnson & Johnson Services, Inc; Agilent Technologies, Inc.; and Epigenomics AG. The players are developing novel kits and therapies and drugs to target population in the areas with high unmet clinical needs.

Further key findings from the study suggest:

• Safety biomarkers captured more than 41% market share in 2019, driven by increasing awareness regarding routine healthcare checkups and reduction in drug attrition

• Validation biomarkers is expected to demonstrate the fastest CAGR through to 2027

• Personalized medicine is likely to expand at a CAGR of 14.8% over the forecast period due to consumer awareness and preferences

• Cancer dominated the disease segment in 2019, driven by a high disease burden and presence of a strong pipeline

• Cardiovascular disease segment is projected to witness the fastest growth in the forthcoming years, supported by the growing obese population base and sedentary lifestyles

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Biomarkers Market Variables, Trends & Scope
3.1. Biomarkers Market Lineage outlook
3.1.1. Clinical diagnostics market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.3.1. Reimbursement framework
3.3.2. Standards & compliances
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic diseases
3.4.1.2. Technological advancements
3.4.1.3. Funding for biomrkers
3.4.2. Market restraint analysis
3.4.2.1. Reimbursement policies
3.5. Biomarkers Market Analysis Tools
3.5.1. Industry analysis – Porter’s
3.5.1.1. Supplier power: (High due to large number of manufacturers)
3.5.1.2. Buyer power: (Moderate due tolong-term contracts with manufacturers)
3.5.1.3. Substitution threat: (Moderate due to no/less external substitutes)
3.5.1.4. Threat from new entrant: (Moderate due to limited number of new players)
3.5.1.5. Competitive rivalry: (High due to mergers & acquisitions by major players)
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Environmental landscape
3.5.2.3. Social landscape
3.5.2.4. Technology landscape
3.5.2.5. Legal landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.3.1. Joint ventures
3.5.3.2. Mergers & acquisitions
3.5.3.3. Licensing & partnership
3.5.3.4. Technology collaborations
3.5.3.5. Strategic divestments
Chapter 4. Biomarkers Market – Competitive Analysis
4.1. Recent Developments & Impact Analysis, By Key Market Participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Vendor Landscape
4.3.1. List of key distributors and channel partners
4.3.2. Key company market share analysis, 2019
4.4. Public Companies
4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.4.2. Company market share
4.4.3. Competitive dashboard analysis
4.4.4. Market differentiators
4.4.5. Synergy analysis: Major deals & strategic alliances
4.5. Private Companies
4.5.1. List of key emerging companies
4.5.2. Regional network map
4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. Biomarkers Market: Type Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Type Market Share Analysis, 2019 & 2027
5.3. Biomarkers Market, by Type, 2015 to 2027
5.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
5.4.1. Safety
5.4.1.1 Safety market, 2015 – 2027 (USD Million)
5.4.2. Efficacy
5.4.2.1 Efficacy market, 2015 – 2027 (USD Million)
5.4.3. Validation
5.4.3.1 Validation market, 2015 – 2027 (USD Million)
Chapter 6. Biomarkers Market: Application Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Application Market Share Analysis, 2019 & 2027
6.3. Biomarkers Market, by Application, 2015 to 2027
6.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
6.4.1. Diagnostics
6.4.1.1 Diagnostics market, 2015 – 2027 (USD Million)
6.4.2. Drug development
6.4.2.1 Drug development market, 2015 – 2027 (USD Million)
6.4.3. Personalized medicine
6.4.3.1 Personalized medicine market, 2015 – 2027 (USD Million)
Chapter 7. Biomarkers Market: Disease Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Disease Market Share Analysis, 2019 & 2027
7.3. Biomarkers Market, by Disease, 2015 to 2027
7.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following,
7.4.1. Cancer
7.4.1.1 Cancer market, 2015 – 2027 (USD Million)
7.4.2. Cardiovascular disease
7.4.2.1 Cardiovascular disease market, 2015 – 2027 (USD Million)
7.4.3. Neurological disease
7.4.3.1 Neurological disease market, 2015 – 2027 (USD Million)
7.4.4. Immunological disease
7.4.4.1 Immunological disease market, 2015 – 2027 (USD Million)
7.4.5. Others
7.4.5.1 Others market, 2015 – 2027 (USD Million)
7.5. Disease Market, by Type, 2015 – 2027:
7.5.1. Cancer
7.5.1.1 Safety
7.5.1.1.1 Cancer biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.1.2 Efficacy
7.5.1.2.1 Cancer biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.1.3 Validation
7.5.1.3.1 Cancer biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.2. Cardiovascular diseases
7.5.2.1 Safety
7.5.2.1.1 Cardiovascular biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.2.2 Efficacy
7.5.2.2.1 Cardiovascular biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.2.3 Validation
7.5.2.3.1 Cardiovascular biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.3. Neurological disease
7.5.3.1 Safety
7.5.3.1.1 Neurological biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.3.2 Efficacy
7.5.3.2.1 Neurological biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.3.3 Validation
7.5.3.3.1 Neurological biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.4. Imunological disease
7.5.4.1 Safety
7.5.4.1.1 Imunological biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.4.2 Efficacy
7.5.4.2.1 Imunological biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.4.3 Validation
7.5.4.3.1 Imunological biomarkers market, by validation, 2015 – 2027 (USD Million)
7.5.5. Others
7.5.5.1 Safety
7.5.5.1.1 Other biomarkers market, by safety, 2015 – 2027 (USD Million)
7.5.5.2 Efficacy
7.5.5.2.1 Other biomarkers market, by efficacy, 2015 – 2027 (USD Million)
7.5.5.3 Validation
7.5.5.3.1 Other biomarkers market, by validation, 2015 – 2027 (USD Million)
Chapter 8 Biomarkers Market: Regional Estimates & Trend Analysis, by Type, Application, & Disease
8.1 Biomarkers Market: Regional Movement Analysis, 2019 & 2027
8.2 Biomarkers Market: Leading Players, 2019:
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4 North America
8.4.1 North America biomarkers market, 2015 – 2027 (USD Million)
8.4.2 U.S.
8.4.2.1 U.S. biomarkers market, 2015 – 2027 (USD Million)
8.4.3 Canada
8.4.3.1 Canada biomarkers market, 2015 – 2027 (USD Million)
8.5. Europe
8.5.1 Europe biomarkers market, 2015 – 2027 (USD Million)
8.5.2 U.K.
8.5.2.1 U.K. biomarkers market, 2015 – 2027 (USD Million)
8.5.3 Germany
8.5.3.1 Germany biomarkers market, 2015 – 2027 (USD Million)
8.5.4 Spain
8.5.4.1 Spain biomarkers market, 2015 – 2027 (USD Million)
8.5.5 France
8.5.5.1 France biomarkers market, 2015 – 2027 (USD Million)
8.5.6 Italy
8.5.6.1 Italy biomarkers market, 2015 – 2027 (USD Million)
8.6 Asia Pacific
8.6.1 Asia Pacific biomarkers market, 2015 – 2027 (USD Million)
8.6.2 Japan
8.6.2.1 Japan biomarkers market, 2015 – 2027 (USD Million)
8.6.3 India
8.6.3.1 India biomarkers market, 2015 – 2027 (USD Million)
8.6.4 South Korea
8.6.4.1 South Korea biomarkers market, 2015 – 2027 (USD Million)
8.6.5 China
8.6.5.1 China biomarkers market, 2015 – 2027 (USD Million)
8.6.6 Australia
8.6.6.1 Australia biomarkers market, 2015 – 2027 (USD Million)
8.7 Latin America
8.7.1 Latin America biomarkers market, 2015 – 2027 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil biomarkers market, 2015 – 2027 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico biomarkers market, 2015 – 2027 (USD Million)
8.7.4 Argentina
8.7.4.1 Argentina biomarkers market, 2015 – 2027 (USD Million)
8.8 MEA
8.8.1 MEA biomarkers market, 2015 – 2027 (USD Million)
8.8.2 South Africa
8.8.2.1 South Africa biomarkers market, 2015 – 2027 (USD Million)
8.8.3 United Arab Emirates
8.8.3.1 United Arab Emirates biomarkers market, 2015 – 2027 (USD Million)
8.8.4 Saudi Arabia
8.8.4.1 Saudi Arabia biomarkers market, 2015 – 2027 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Heat Map Analysis of Private Companies
9.2.1 Company size
9.2.2 Distribution network
9.2.3 Product portfolio
9.2.4 Segment coverage
9.2.5 Geographic presence
9.2.6 Collaborations
9.2.7 Conclusion
9.3 F-Hoffman La Roche Ltd.
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Abbott
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 Epigenomics AG
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 General Electric Company
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 Johnson & Johnson
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Thermo Fisher Scientific, Inc.
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 Bio-Rad Laboratories, Inc.
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Siemens Healthcare Private Limited
9.10.1 Company overview
9.10.1 Financila performance
9.10.2 Product benchmarking
9.10.3 Strategic initiatives
9.11 Qiagen
9.11.1 Company Overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives

List of Tables

TABLE 1 State wise naturopathy & yoga practitioners, India
TABLE 2 Adoption of CAM in the U.S., by diseases
TABLE 3 North America complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 4 North America botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 5 North America mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 6 North America. energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 7 North America magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 8 North America complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 9 U.S. complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 10 U.S. botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 11 U.S. mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 12 U.S. energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 13 U.S. magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 14 U.S. complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 15 Canada complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 16 Canada botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 17 Canada mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 18 Canada energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 19 Canada magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 20 Canada complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 21 Europe complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 22 Europe botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 23 Europe mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 24 Europe energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 25 Europe magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 26 Europe complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 27 Germany complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 28 Germany botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 29 Germany mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 30 Germany energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 31 Germany magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 32 Germany complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 33 France complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 34 France botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 35 France mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 36 France energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 37 France magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 38 France complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 39 U.K. complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 40 U.K. botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 41 U.K. mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 42 U.K. energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 43 U.K. magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 44 U.K. complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 45 Switzerland complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 46 Switzerland botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 47 Switzerland mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 48 Switzerland energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 49 Switzerland magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 50 Switzerland complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 51 Austria complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 52 Austria botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 53 Austria mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 54 Austria energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 55 Austria magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 56 Austria complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 57 Spain complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 58 Spain botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 59 Spain mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 60 Spain energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 61 Spain magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 62 Spain complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 63 Norway complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 64 Norway botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 65 Norway mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 66 Norway energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 67 Norway magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 68 Norway complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 69 Denmark complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 70 Denmark botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 71 Denmark mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 72 Denmark energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 73 Denmark magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 74 Denmark complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 75 Sweden complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 76 Sweden botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 77 Sweden mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 78 Sweden energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 79 Sweden magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 80 Sweden complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 81 Belgium complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 82 Belgium botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 83 Belgium mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 84 Belgium energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 85 Belgium magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 86 Belgium complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 87 Netherlands complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 88 Netherlands botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 89 Netherlands mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 90 Netherlands energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 91 Netherlands magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 92 Netherlands complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 93 Ireland complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 94 Ireland botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 95 Ireland mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 96 Ireland energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 97 Ireland magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 98 Ireland complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 99 Asia Pacific complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 100 Asia Pacific botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 101 Asia Pacific mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 102 Asia Pacific energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 103 Asia Pacific magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 104 Asia Pacific complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 105 China complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 106 China botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 107 China mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 108 China energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 109 China magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 110 China complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 111 India complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 112 India botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 113 India mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 114 India energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 115 India magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 116 India complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 117 Japan complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 118 Japan botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 119 Japan mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 120 Japan energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 121 Japan magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 122 Japan complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 123 Australia complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 124 Australia botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 125 Australia mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 126 Australia energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 127 Australia magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 128 Australia complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 129 New Zealand complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 130 New Zealand botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 131 New Zealand mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 132 New Zealand energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 133 New Zealand magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 134 New Zealand complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 135 Singapore complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 136 Singapore botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 137 Singapore mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 138 Singapore energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 139 Singapore magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 140 Singapore complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 141 Hong Kong complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 142 Hong Kong botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 143 Hong Kong mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 144 Hong Kong energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 145 Hong Kong magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 146 Hong Kong complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 147 Latin America complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 148 Latin America botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 149 Latin America mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 150 Latin America energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 151 Latin America magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 152 Latin America complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 153 Brazil complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 154 Brazil botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 155 Brazil mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 156 Brazil energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 157 Brazil magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 158 Brazil complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 159 Mexico complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 160 Mexico botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 161 Mexico mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 162 Mexico energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 163 Mexico magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 164 Mexico complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 165 Argentina complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 166 Argentina botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 167 Argentina mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 168 Argentina energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 169 Argentina magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 170 Argentina complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 171 MEA complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 172 MEA botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 173 MEA mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 174 MEA energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 175 MEA magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 176 MEA complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 177 UAE complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 178 UAE botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 179 UAE mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 180 UAE energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 181 UAE magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 182 UAE complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 183 South Africa complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 184 South Africa botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 185 South Africa mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 186 South Africa energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 187 South Africa magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 188 South Africa complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)
TABLE 189 Israel complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 190 Israel botanicals-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 191 Israel mind/ body healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 192 Israel energy healing-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 193 Israel magnetic intervention-based complementary and alternative medicine market estimates and forecasts, by intervention, 2016 - 2027 (USD Billion)
TABLE 194 Israel complementary and alternative medicine market estimates and forecasts, by distribution method, 2016 - 2027 (USD Billion)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market model for CAM market
FIG. 8 Penetration of CAM providers regulated by Member States
FIG. 9 Growth in the number of Member States with a national policy on CAM, 1999-2018
FIG. 10 Member states with policy on CAM & herbal regulation
FIG. 11 Market segmentation & scope
FIG. 12 Market summary
FIG. 13 Market trends & outlook
FIG. 14 Penetration & growth prospect mapping, by intervention, 2019
FIG. 15 Market driver relevance analysis (Current & future impact)
FIG. 16 Most commonly adopted CAM, the U.S.
FIG. 17 Penetration of complementary and alternative medicine in the U.S., adult versus children
FIG. 18 Penetration of complementary and alternative medicine in the U.S., by age
FIG. 19 Usage growth rate in complementary and alternative therapies in Canada, 1997-2016
FIG. 20 Market restraint relevance analysis (Current & future impact)
FIG. 21 Market opportunity relevance analysis (Current & future impact)
FIG. 22 Market challenges relevance analysis (Current & future impact)
FIG. 23 Impact analysis by key market participants
FIG. 24 Company market position analysis
FIG. 25 Complementary and alternate medicine market: Intervention outlook key takeaways
FIG. 26 Complementary and alternative medicine market: Intervention movement analysis
FIG. 27 Global botanicals complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 28 Global ayurveda complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 29 Global naturopathy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 30 Global homeopathy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 31 Global mind/ body healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 32 Global yoga complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 33 Global meditation complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 34 Global energy healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 35 Global Eden energy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 36 Global other energy healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 37 Global chakra healing complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 38 Global hypnotherapy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 39 Global kinesiology complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 40 Global magnetic intervention complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 41 Global magnetic resonance therapy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 42 Global bio-magnetic therapy complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 43 Global accupunture complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 44 Complementary and alternate medicine market: Distribution method outlook key takeaways
FIG. 45 Complementary and alternative medicine market: Distribution method movement analysis
FIG. 46 Global direct sales-based complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 47 Global E-sales-based complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 48 Global distance correspondence-based complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 49 Regional market place: Key takeaways
FIG. 50 Regional outlook, 2019 & 2027
FIG. 51 North America complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 52 U.S. complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 53 Canada complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 54 Europe complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 55 Germany complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 56 France complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 57 U.K. complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 58 Switzerland complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 59 Austria complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 60 Spain complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 61 Norway complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 62 Denmark complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 63 Sweden complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 64 Belgium complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 65 Netherlands complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 66 Ireland complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 67 Asia Pacific complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 68 China complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 69 India complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 70 Japan complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 71 Australia complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 72 New Zealand complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 73 Singapore complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 74 Hong Kong complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 75 Latin America complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 76 Brazil complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 77 Mexico complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 78 Argentina complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 79 MEA complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 80 UAE complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 81 South Africa complementary and alternative medicine market, 2016 - 2027 (USD Billion)
FIG. 82 Israel complementary and alternative medicine market, 2016 - 2027 (USD Billion)

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[バイオマーカーの世界市場：種類別（安全性、有効性、検証）、用途別（診断、医薬品開発、個別化医療）、疾患別]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. バイオマーカーの世界市場：製品、種類、用途、疾病、地域別分析
    MAM-BT-2120 / MarketsandMarkets / 2015年7月17日 / 当調査レポートでは、バイオマーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、製品別分析、種類別分析、用途別分析、疾病別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。...In this report, the biomarkers market is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers. The applications segments included in this report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications. The disease indications segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases. The geographic segments included in this report are North America, Europe, Asia, and the...
  2. バイオマーカーの世界市場：疾患別（がん、心血管障害、感染症、神経障害、免疫的障害、その他）、用途別（診断、創薬、開発、その他）、最終用途別（病院、研究所、通院外科診療所、診断ラボ）、製品の種類別（バイオマーカー検査キット、バイオマーカーアナライザー）、地域別予測
    BZW9MR055 / Bizwit Research & Consulting / 2019年3月13日 / 本資料は、バイオマーカーの世界市場について調べ、バイオマーカーの世界規模、市場動向、市場環境、疾患別（がん、心血管障害、感染症、神経障害、免疫的障害、その他）分析、用途別（診断、創薬、開発、その他）分析、最終用途別（病院、研究所、通院外科診療所、診断ラボ）分析、製品の種類別（バイオマーカー検査キット、バイオマーカーアナライザー）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはAbbott Laboratories、Medtronic、BG Medicine Inc.、Hoffmann LA Roche Ltd.、Siemens Healthnineers 、Nexus-DX、Qiagen N.V.、Lifesign...Global Biomarker Market to reach USD XX billion by 2025. Global Biomarker Market valued approximately USD 29.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2018-2025. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of...
  3. 創薬インフォマティクスの世界市場予測：機能別（ターゲットデータ、シーケンスデータ分析、ドッキング）、ソリューション別（ソフトウェア、サービス）、用途別（医薬品開発）、エンドユーザー別（製薬、バイオテクノロジー、受託研究機関）
    HIT 5838 / MarketsandMarkets / 2020年4月30日 / MarketsandMarkets社は創薬インフォマティクスの世界市場が、2020年22億ドルから2025年35億ドルまで、年平均9.3％成長すると予測しています。本調査レポートでは、創薬インフォマティクスの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、機能別（シークエンシング・ターゲットデータ分析、ドッキング、分子モデリング、その他）分析、用途別（医薬品開発、創薬）分析、ソリューション別（ソフトウェア、サービス）分析、エンドユーザー別（製薬会社、バイオテクノロジー企業、受託研究機関）分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・創薬インフォマティクスの世界市場：機能別（シークエンシング・ターゲットデータ分析、ドッキング、分子モデリング、その他） ・創薬インフォマティクスの世界市場：用途別（医薬品開発、創薬） ・創薬インフォマティクスの世界市場：ソリューション別（ソフトウェア、サービス） ・創薬インフォマティクスの世界市場：エンドユーザー別（製薬会社、バイオテクノロジー企業、受託研究機関）...“The rising R&D expenditure, growing support for research, stringent regulatory guidelines especially in the area of rare diseases, and the rising use of informatics in drug discovery are expected to drive the overall growth of the drug discovery informatics market.” The global drug discovery informatics market is projected to reach USD 3.5 billion in 2025 from USD 2.2 billion in 2020, at a CAGR of 9.3% during the forecast period. Market growth is largely driven by factors such as the rising R&D expenditure, growing support for research, especially in the area of rare diseases, and the rising use of informatics...
  4. 歯科インプラントの世界市場：種類別（チタン、ジルコニウム）、地域別（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA）
    GV20MY046 / Grand View Research / 2020年3月4日 / 本調査レポートでは、歯科インプラントの世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、種類別（チタン歯科インプラント、ジルコニア歯科インプラント）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東及びアフリカ）分析、競争分析などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・歯科インプラントの世界市場：種類別（チタン歯科インプラント、ジルコニア歯科インプラント） ・歯科インプラントの世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東及びアフリカ） ・競争分析...The global dental implants market size is expected to reach a value of USD 9.0 billion by 2027, registering a CAGR of 9.0% over the forecast period, according to a new report by Grand View Research, Inc. Rising demand for tooth replacement has provided good growth potential to the market. Increasing number of dental injuries owing to road accidents and sports injuries are some of the major factors boosting the demand. With growing aesthetic awareness, people are exploring more treatment options, which is leading to the growth of the market. For instance, as per the American Academy of Cosmetic Dentistry...
  5. 使い捨て内視鏡の世界市場：用途別（気管支鏡検査、直腸鏡検査、関節鏡検査）、最終用途別（病院、診断センター、クリニック）
    GV20MY048 / Grand View Research / 2020年3月4日 / 本調査レポートでは、使い捨て内視鏡の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、用途別（気管支鏡検査、泌尿器内視鏡検査、関節鏡検査、胃腸内視鏡検査、ENT内視鏡検査、その他）分析、最終用途別（病院、診断センター、その他）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・使い捨て内視鏡の世界市場：用途別（気管支鏡検査、泌尿器内視鏡検査、関節鏡検査、胃腸内視鏡検査、ENT内視鏡検査、その他） ・使い捨て内視鏡の世界市場：最終用途別（病院、診断センター、その他） ・使い捨て内視鏡の世界市場：地域別 ・競争状況...The global disposable endoscopes market size is expected to reach USD 4.45 billion by 2027 and is expected to expand at a CAGR of 19.8% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing incidence of Hospital-acquired Infections (HAI) is one of the pivotal factors attributed to the growth. Furthermore, high capital cost associated with cleaning, maintenance, reprocessing and storage cabinets and equipment is also of the factors compelling healthcare establishments to opt of disposable endoscopes. Increasing prevalence of target diseases including cancer, ENT, Neurological, GI disorders and others is further boosting the...
  6. クリーンルーム技術の世界市場：製品タイプ別（機器、消耗品）、最終用途別（医薬品、医療機器、バイオテクノロジー）、地域別
    GV20MY038 / Grand View Research / 2020年3月16日 / 本調査レポートでは、クリーンルーム技術の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、産業概要、製品タイプ別（機器、消耗品）分析、最終用途別（医薬品、医療機器、バイオテクノロジー）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法 ・エグゼクティブサマリー ・産業概要 ・クリーンルーム技術の世界市場：製品タイプ別（機器、消耗品） ・クリーンルーム技術の世界市場：最終用途別（医薬品、医療機器、バイオテクノロジー） ・クリーンルーム技術の世界市場：地域別 ・競争状況...The global cleanroom technology market size is expected to reach USD 5.3 billion by 2027, expanding at a CAGR of 3.8%, according to a new report by Grand View Research, Inc. Technological advancement in cleanroom equipment, increasing need for cleanroom technology to develop quality products, and initiatives taken by private and public organizations to create awareness are key factors driving market growth. Manufacturing companies in various industries are dependent on cleanroom technology in order to comply with the stringent regulatory standards. Moreover, there has been an increase in need for standardizing cleanroom standards due to presence of a wide range...
  7. 希少バイオマーカー検体採取・安定化の世界市場2020-2027：バイオマーカー・製品別（チューブ、分離キット）、最終用途別、地域別
    GV20JN259 / Grand View Research / 2020年4月 / 本調査レポートでは、希少バイオマーカー検体採取・安定化の世界市場を調査・分析し、エグゼクティブサマリー、調査手法、市場の要因・動向・範囲、バイオマーカー・製品別（チューブ、分離キット）分析、最終用途別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・調査手法 ・市場の要因・動向・範囲 ・希少バイオマーカー検体採取・安定化の世界市場規模：バイオマーカー・製品別（チューブ、分離キット） ・希少バイオマーカー検体採取・安定化の世界市場規模：最終用途別 ・希少バイオマーカー検体採取・安定化の世界市場規模：地域別 ・企業情報...The global rare biomarkers specimen collection and stabilization market size is expected to reach USD 60.7 billion by 2027, expanding at a CAGR of 10.6% over the forecast period, according to a new report by Grand View Research, Inc. Expanding potential applications of circulating rare biomarkers has created lucrative opportunities for the technology developers that are engaged in the introduction of products to support the effective and rapid collection and stabilization of these rare biomarkers specimen. Furthermore, the emergence of liquid biopsy for cancer screening, diagnosis, prognosis, and treatment monitoring has significantly enhanced the competition and capabilities in the market...
  8. スポーツ栄養の世界市場：製品別（ドリンク、サプリメント、食品）、流通経路別（eコマース、店舗販売）、地域別
    GV20MY074 / Grand View Research / 2020年2月28日 / 本調査レポートでは、スポーツ栄養の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別（ドリンク、サプリメント、食品）分析、流通経路別（eコマース、店舗販売）分析、地域別分析、競争状況などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・スポーツ栄養の世界市場：製品別（ドリンク、サプリメント、食品） ・スポーツ栄養の世界市場：流通経路別（eコマース、店舗販売） ・スポーツ栄養の世界市場：地域別 ・競争状況...The global sports nutrition market size is expected to reach USD 31.0 billion by 2027, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing importance of an active lifestyle owing to rise in sedentary jobs and shift in demographic base from core athletes to recreational athletes and lifestyle users are the key factors expected to drive the market. Moreover, increasing number of health and fitness centers and gyms, rising consumer awareness regarding the adoption of a healthy lifestyle, and demand for these products from athletes is expected to boost...
  9. ホルモン補充療法の世界市場：製品別（エストロゲン、人間成長）、投与経路別（経口、非経口）、疾患種類別、地域別
    GV20MY053 / Grand View Research / 2020年2月17日 / 本調査レポートでは、ホルモン補充療法の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別（エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法）分析、投与経路別（経口、非経口、経皮、その他）分析、疾患種類別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他）分析、地域別分析、競争分析などの構成でお届けいたします。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場要因・動向・範囲 ・ホルモン補充療法の世界市場：製品別（エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法） ・ホルモン補充療法の世界市場：投与経路別（経口、非経口、経皮、その他） ・ホルモン補充療法の世界市場：疾患種類別（更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他） ・ホルモン補充療法の世界市場：地域別 ・競争分析...The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy. Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill,...
  10. 皮膚リサーフェシングの世界市場2020-2027：タイプ別（アブレイティブ、非アブレイティブ）、製品別、最終用途別、用途別、地域別
    GV20JN095 / Grand View Research / 2020年5月 / 本調査レポートでは、皮膚リサーフェシングの世界市場を調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場の要因・動向・範囲、タイプ別（アブレイティブ、非アブレイティブ）分析、製品別分析、最終用途別分析、用途別分析、地域別分析、競争分析など、今後の市場展望をまとめております。 ・調査手法・範囲 ・エグゼクティブサマリー ・市場の要因・動向・範囲 ・皮膚リサーフェシングの世界市場規模：タイプ別（アブレイティブ、非アブレイティブ） ・皮膚リサーフェシングの世界市場規模：製品別 ・皮膚リサーフェシングの世界市場規模：最終用途別 ・皮膚リサーフェシングの世界市場規模：用途別 ・皮膚リサーフェシングの世界市場規模：地域別 ・競争分析...Skin Resurfacing Market Growth & Trends The global skin resurfacing market size is expected to reach a value of USD 378.4 million by 2027, expanding at a CAGR of 7.2%, according to a new report by Grand View Research, Inc. High incidence of medical conditions such as acne in adolescents and a rapidly aging population is anticipated to drive the market. High influence of social media and rise in usage of smartphones and photo editing applications is anticipated to fuel a desire for flawless and glowing face, thereby increasing the demand for the rejuvenation services. For instance, Facebook, YouTube, Instagram,...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆